Lymphomas
A PHASE 1B, MULTI-CENTER, OPEN-LABEL STUDY OF NOVEL COMBINATIONS OF CC-122, CC-223, CC-292, AND RITUXIMAB IN DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA (CC-122-DLBCL-001)
- Details
ClinicalTrials.gov ID:
NCT02031419
Diagnosis Type:
Non-Hodgkins
USOR Number:
13092
- Address
10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950